Submission Details
| 510(k) Number | K000238 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | January 27, 2000 |
| Decision Date | April 14, 2000 |
| Days to Decision | 78 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | Summary PDF |
K000238 is an FDA 510(k) clearance for the HSV-1 & HSV-2 DIFFERENTIATION IMMUNOBLOT IGG, MODEL IB0900G, a Enzyme Linked Immunoabsorbent Assay, Herpes Simplex Virus, Non-specific (Class II — Special Controls, product code LGC), submitted by Mrl Diagnostics (Cypress, US). The FDA issued a Cleared decision on April 14, 2000, 78 days after receiving the submission on January 27, 2000. This device falls under the Microbiology review panel. Regulated under 21 CFR 866.3305.
| 510(k) Number | K000238 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | January 27, 2000 |
| Decision Date | April 14, 2000 |
| Days to Decision | 78 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | Summary PDF |
| Product Code | LGC — Enzyme Linked Immunoabsorbent Assay, Herpes Simplex Virus, Non-specific |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 866.3305 |